C. Suha Et Al. , "Infliximab, an anti-TNF-alpha agent, improves left atrial abnormalities in patients with rheumatoid arthritis: preliminary results," CARDIOVASCULAR JOURNAL OF AFRICA , vol.25, no.4, pp.168-175, 2014
Suha, C. Et Al. 2014. Infliximab, an anti-TNF-alpha agent, improves left atrial abnormalities in patients with rheumatoid arthritis: preliminary results. CARDIOVASCULAR JOURNAL OF AFRICA , vol.25, no.4 , 168-175.
Suha, C., Gokhan, V. M., Goksal, K., Ekrem, Y., Mehmet, D., & Akif, O. M., (2014). Infliximab, an anti-TNF-alpha agent, improves left atrial abnormalities in patients with rheumatoid arthritis: preliminary results. CARDIOVASCULAR JOURNAL OF AFRICA , vol.25, no.4, 168-175.
Suha, Cetin Et Al. "Infliximab, an anti-TNF-alpha agent, improves left atrial abnormalities in patients with rheumatoid arthritis: preliminary results," CARDIOVASCULAR JOURNAL OF AFRICA , vol.25, no.4, 168-175, 2014
Suha, Cetin Et Al. "Infliximab, an anti-TNF-alpha agent, improves left atrial abnormalities in patients with rheumatoid arthritis: preliminary results." CARDIOVASCULAR JOURNAL OF AFRICA , vol.25, no.4, pp.168-175, 2014
Suha, C. Et Al. (2014) . "Infliximab, an anti-TNF-alpha agent, improves left atrial abnormalities in patients with rheumatoid arthritis: preliminary results." CARDIOVASCULAR JOURNAL OF AFRICA , vol.25, no.4, pp.168-175.
@article{article, author={Cetin Suha Et Al. }, title={Infliximab, an anti-TNF-alpha agent, improves left atrial abnormalities in patients with rheumatoid arthritis: preliminary results}, journal={CARDIOVASCULAR JOURNAL OF AFRICA}, year=2014, pages={168-175} }